Jianbing Wu

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 31, 2026
Current advances in immunotherapy for KRAS-Mutant pancreatic cancer.

|Nov 29, 2025
Comparative efficacy and safety of lenvatinib, sintilimab combined interventional therapy vs bevacizumab, sintilimab combined interventional therapy in intermediate and advanced hepatocellular carcinoma: a multicenter retrospective study.

Yi-Xin Yuan, Lin Xu, Shu-Min Fu

|Apr 30, 2024
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.

Shumin Fu, Yongkang Xu, Ye Mao

Pageof 1

Frequent Collaborators

1 joint publications

Shumin Fu

1 joint publications

Yongkang Xu

1 joint publications

Man Li

1 joint publications

Xiao Wang